Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Axsome Therapeutics Inc., 3 years.
Axsome Therapeutics Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Axsome Therapeutics Inc. June 7, 202480.3%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Axsome Therapeutics Inc. | Open-market sale | −643 | $249.00 | $160,107 |
| Jun 8, 2026 | Axsome Therapeutics Inc. | Option exercise | +1,429 | — | — |
| Jun 2, 2026 | Axsome Therapeutics Inc. | Open-market sale | −5,537 | $223.39 | $1,236,910 |
| Jun 1, 2026 | Axsome Therapeutics Inc. | Open-market sale | −6,000 | $230.30 | $1,381,800 |
| May 29, 2026 | Axsome Therapeutics Inc. | Open-market sale | −6,000 | $233.46 | $1,400,760 |
| Feb 26, 2026 | Axsome Therapeutics Inc. | Open-market sale | −25,000 | $161.11 | $4,027,750 |
| Feb 23, 2026 | Axsome Therapeutics Inc. | Option exercise | +6,250 | $4.95 | $30,938 |
| Feb 20, 2026 | Axsome Therapeutics Inc. | Option exercise | +12,485 | $4.95 | $61,801 |
| Feb 10, 2026 | Axsome Therapeutics Inc. | Option exercise | +5,193 | $8.02 | $41,648 |
| Sep 8, 2025 | Axsome Therapeutics Inc. | Open-market purchase | +800 | $127.20 | $101,760 |
| Sep 8, 2025 | Axsome Therapeutics Inc. | Open-market purchase | +287 | $127.30 | $36,535 |
| Sep 8, 2025 | Axsome Therapeutics Inc. | Open-market purchase | +488 | $127.40 | $62,171 |
| May 28, 2025 | Axsome Therapeutics Inc. | Open-market sale | −3,750 | $103.43 | $387,863 |
| May 27, 2025 | Axsome Therapeutics Inc. | Open-market sale | −3,750 | $105.47 | $395,513 |
| May 20, 2025 | Axsome Therapeutics Inc. | Open-market sale | −3,000 | $107.49 | $322,470 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.